|
medpundit |
||
 |
 |
|
Monday, April 26, 2004Researchers looked at patient's 'ejection fraction' - a standard measure of heart performance, determined by the total amount of blood pumped out by the left ventricle. A normal person has an ejection fraction of 55%. When the trial began, all patients had ejection fractions of less than 35%. All patients underwent heart by-pass surgery. During the operation, selected patients were given two types of stem cells taken from their hip bones. The cells were injected into 25 to 30 sites where the heart muscle was damaged. After six months, the group receiving stem cell therapy had an average ejection fraction rate of 46.1%. Those who had surgery alone had an average of only 37.2%. The treatment did not appear to cause any serious side effects, such as abnormal heart rhythms. posted by Sydney on 4/26/2004 08:20:00 AM 0 comments 0 Comments: |
|
